Journal of Research in Medical Sciences1735-19952827202302251140911409EN20230225<p>Background: Endoscopic retrograde cholangiopancreatography (ERCP) is one of the main therapeutic and sometimes diagnostic methods in biliary and pancreatic diseases. A grading system for the difficulty of ERCP  grade one to four, the higher grade represents the more complexity of the procedure) has been developed by the American Society for Gastrointestinal Endoscopy (ASGE). This study aimed to assess the prevalence of ERCP?related complications, their common risk factors, and specifically the role of difficulty of the procedure based on ASGE grading.</p><p>Material and Methods: This cross?sectional study was performed on 620 ERCP?operated patients over 4 years in two tertiary referral centers affiliated with Isfahan University of Medical Sciences. Data about the difficulty of procedures based on the ASGE grading scale, complications including pancreatitis, bleeding, infection, perforation, arrhythmia, respiratory suppression, aspiration, and major common risk factors were collected.</p><p>Results: The overall prevalence of complications was 11.6% including pancreatitis 8.2%, perforation 0.8%, gastrointestinal bleeding 1.3%, cholangitis 2.4%, and cardiopulmonary problems 0.5% (arrhythmia 0.3% and respiratory depression 0.2%). Patients with pancreatic contrast injection (66.7% vs. 11.3% P = 0.04) and sphincter of Oddi dysfunction (SOD) (44.4% vs. 11.1%; P = 0.01) showed a statistically significant higher overall complication rate. The association of these risk factors remained significant in multivariable logistic regression analysis. Patients with pancreatic contrast injection also showed a statistically significant higher prevalence of post?ERCP pancreatitis (66.7% vs. 11.3% P = 0.04). Furthermore, a significantly higher prevalence of arrhythmia (3.6% vs. 0; P = 0.008) was observed among patients with difficult cannulation. Based<br />on the ASGE difficulty grading score, most of the patients were classified as grade 2 (74.2%) and 3 and 4 (23.4%). No statistically significant  difference was noted between the difficulty?based groups in terms of complications.</p><p>Conclusion: The current study showed that the most critical risk factors of ERCP?induced complications were pancreatic contrast injection and SOD. ASGE grading scale for ERCP complexity did not predict the occurrence of complications in our study population.<br /><br /><br /></p>http://jrms.mui.ac.ir/index.php/jrms/article/view/11409http://jrms.mui.ac.ir/index.php/jrms/article/download/11409/6220

Journal of Research in Medical Sciences1735-19952827202302251141411414EN20230225<p>Background: Understanding the contributing of influence inflammatory biomarkers in asthmatic patients with metabolic syndrome is more important. Whereby, the present study considering the important association of NADPH oxidase4 (NOX4) and Toll- like receptor4 (TLR4) in the respiratory inflammatory responses in asthmatic patients with  etabolic syndrome (AS-MetS) and asthmatic (AS) patients.</p><p>Materials and Methods: In this case-control study, 30 AS and 34 AS-MetS patients were enrolled. The Peripheral blood mononuclear cells (PBMCs) mRNA and protein levels of TLR4 and NOX4 were measured by qRT-PCR<br />and western blot, respectively. Then their correlation was evaluated.</p><p>Results: The significant down-regulation of mRNA and protein PBMCs expression levels of TLR4 were observed in the AS-MetS group in comparison to AS one (P=0.03), but the NOX4 expression was non- significant. Additionally, the significant correlation was exhibited between mRNA expression levels of NOX4 and TLR4 in both AS-MetS (r= 0.440, P=0.009) and AS groups (r=0.909, P=0.0001). The association between TLR4 mRNA level and triglyceride in AS-MetS group (r=0.454, P=0.008,) and also white blood cells (WBC) in AS group (r= -0.507, P=0.006,) were<br />significant.</p><p>Conclusion: The metabolic syndrome can significantly influence the expressions of TLR4 in AS-MetS. This study indicated that TLR4 and NOX4 altogether may provide valuable molecular knowledge of their relation with metabolic syndrome criteria for finding major pathways in different phenotype of asthma</p>http://jrms.mui.ac.ir/index.php/jrms/article/view/11414http://jrms.mui.ac.ir/index.php/jrms/article/download/11414/6225

Journal of Research in Medical Sciences1735-19952827202302251141111411EN20230225<p>Background: Some studies showed the cerebrovascular manifestation in patients with recently pandemic coronavirus 2 named the coronavirus disease 2019 (COVID?19). However, there are rare reports about stroke subtypes in these patients. Here, we reported the stroke subtype in patients with laboratory?confirmed diagnosis of COVID?19 and treated at our hospitals, which are located in Isfahan, Iran.</p><p>Materials and Methods: This is a retrospective, observational case series. Data were collected from March 01, 2020, to May 20, 2020, at three designated special care centers for COVID?19 of Isfahan University of Medical Sciences. The study included 1188 consecutive hospitalized patients with laboratory?confirmed diagnosis of COVID?19.</p><p>Results: Of 1188 COVID?19 patients, 7 (0.5%) patients developed stroke. Five (0.4%) had ischemic arterial stroke, 1 (0.08%) hemorrhagic stroke and 1(0.08 %) cerebral venous and sinus thrombosis. Sixty percent of ischemic stroke were cardioembolic stroke (CE) and the rest 2 (40%) were embolic stroke of undetermined source. Three male patients (40%) had stroke as a presenting and admitted symptom of COVID?19. Four<br />patients (57%) had severe COVID?19. Conclusion: Stroke was an uncommon manifestation in COVID?19 patients. CE was a common<br />subtype of stroke in COVID?19 patients in our centers.</p>http://jrms.mui.ac.ir/index.php/jrms/article/view/11411http://jrms.mui.ac.ir/index.php/jrms/article/download/11411/6222

Journal of Research in Medical Sciences1735-19952827202302251141211412EN20230225<p>Background: Blood loss of postoperative after prostate surgery could be related with an increase in urinary fibrinolytic activity. Tranexamic acid (TXA) is both a potent inhibitor of plasminogen and urokinase activators and a low molecular weight substance that is excreted unchanged in the urinary tract and can be administered both orally and intravenously. This study aimed to evaluate the effectiveness TXA administration in reducing bleeding in benign prostatic hyperplasia (BPH) patients who underwent open prostatectomy.</p><p>Materials and Methods: This double?blind randomized clinical trial was conducted on patients with BPH who underwent open prostatectomy. The first group received TXA (1 gr IV from during surgery to 48 h after surgery, 3 times/day). Twenty?four hours after surgery, the two groups were compared in terms of bleeding rate. Hemoglobin (Hb), hematocrit (HCT), and platelet (Plt) counts were also assessed before and after the intervention.</p><p>Results: Intervention and control groups were comparable in terms of basic and baseline values of variables at the beginning of the study (P &gt; 0.05). The mean bleeding volume in TXA group was significantly lower than the control group 112.11 ± 53.5 and 190.00 ± 97.5 CC; P ? 0.001). Mean hospitalization (3.28±0.46 vs. 4.38 ± 0.95 days P &lt; 0.001) and surgery duration (98.11 ± 37.11 vs. 128.00 ± 39.12 h; P = 0.001) were significantly lower in TXA group compared to control intervention.</p><p>Conclusion: According to the findings of the current study, the administration of TXA led to reduce bleeding in BPH patients who underwent open prostatectomy. Furthermore, the mean Hb, HCT, levels were significantly affected by TXA. TXA treatment approach also can reduce the surgery and hospitalization time effectively. TXA approach is recommended as effective procedure in BPH patients who underwent open prostatectomy.</p>http://jrms.mui.ac.ir/index.php/jrms/article/view/11412http://jrms.mui.ac.ir/index.php/jrms/article/download/11412/6223

Journal of Research in Medical Sciences1735-19952827202302251141311413EN20230225<p>Background: Chronic mental illnesses (CMI) are long lasting and reoccurring and require continuous care as well as an integrated and<br />collaborative approach to organize the care. This study sought to examine whether family centered collaborative care is an acceptable<br />treatment option for individuals with CMI.</p><p>Materials and Methods: From the years 2000 to 2021, ten electronic databases relating to family centered collaborative care for mental illness were searched adopting Preferred Reporting Items for Systematic Reviews and Meta Analysis checklist. Twenty seven relevant articles and a thesis from among 6956 studies retrieved, were assessed their quality appraisal through four standardized tools. The studies were rated as good, moderate, or poor. Studies were calibrated, different opinions were discussed, and extracted data were done.</p><p>Results: Evidence included 11 randomized controlled trials (from 19 articles), one randomized control trial, three mixed methods studies (from 3 articles and 1 thesis), and a qualitative study (from 4 articles).<br />The quality of seven studies was good, 15 were moderate quality, and seven were poor quality. According to moderate to high quality qualitative research, family centered collaborative care was considered an  cceptable intervention; though a few studies supported it.</p><p>Conclusion: The findings demonstrated that family involvement in the care of patients with CMI affects no recurrence of the disease, and no re hospitalization of patients with this disorder. As a result, engaging family members in the care process can have a positive impact on the health and well being of these patients.</p>http://jrms.mui.ac.ir/index.php/jrms/article/view/11413http://jrms.mui.ac.ir/index.php/jrms/article/download/11413/6224

Journal of Research in Medical Sciences1735-19952827202302251141011410EN20230225---http://jrms.mui.ac.ir/index.php/jrms/article/view/11410http://jrms.mui.ac.ir/index.php/jrms/article/download/11410/6221